AT344881B - Verfahren zur herstellung von antihaemophilfaktor (ahf)-konzentrat - Google Patents

Verfahren zur herstellung von antihaemophilfaktor (ahf)-konzentrat

Info

Publication number
AT344881B
AT344881B AT433573A AT433573A AT344881B AT 344881 B AT344881 B AT 344881B AT 433573 A AT433573 A AT 433573A AT 433573 A AT433573 A AT 433573A AT 344881 B AT344881 B AT 344881B
Authority
AT
Austria
Prior art keywords
antihaemophil
ahf
concentrate
factor
producing
Prior art date
Application number
AT433573A
Other languages
English (en)
Other versions
ATA433573A (de
Inventor
Lajos F Fekete
Stephen L Holst
Original Assignee
Baxter Travenol Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Travenol Lab filed Critical Baxter Travenol Lab
Publication of ATA433573A publication Critical patent/ATA433573A/de
Application granted granted Critical
Publication of AT344881B publication Critical patent/AT344881B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Golf Clubs (AREA)
  • Developing Agents For Electrophotography (AREA)
AT433573A 1972-05-17 1973-05-17 Verfahren zur herstellung von antihaemophilfaktor (ahf)-konzentrat AT344881B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00254148A US3803115A (en) 1972-05-17 1972-05-17 Stabilization of ahf using heparin

Publications (2)

Publication Number Publication Date
ATA433573A ATA433573A (de) 1975-04-15
AT344881B true AT344881B (de) 1978-08-10

Family

ID=22963114

Family Applications (1)

Application Number Title Priority Date Filing Date
AT433573A AT344881B (de) 1972-05-17 1973-05-17 Verfahren zur herstellung von antihaemophilfaktor (ahf)-konzentrat

Country Status (18)

Country Link
US (2) US3803115A (de)
JP (1) JPS596845B2 (de)
AT (1) AT344881B (de)
AU (1) AU465351B2 (de)
BE (1) BE799525A (de)
CA (1) CA1007986A (de)
CH (1) CH630804A5 (de)
DE (1) DE2324717C3 (de)
DK (1) DK136016B (de)
ES (1) ES414823A1 (de)
FR (1) FR2184898B1 (de)
GB (1) GB1372515A (de)
IL (1) IL42221A (de)
IT (1) IT1061433B (de)
NL (1) NL7306806A (de)
NO (1) NO142381C (de)
SE (1) SE430020B (de)
ZA (1) ZA733138B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920625A (en) * 1973-06-19 1975-11-18 Kabi Ab Isolation of coagulation factors from biological material using cross linked sulfated, sulfonated carbohydrates
US4022758A (en) * 1973-06-19 1977-05-10 Ab Kabi Isolation of coagulation factors I and VIII from biological material
US3973002A (en) * 1974-04-12 1976-08-03 E. R. Squibb & Sons, Inc. Antihemophilic factor
US4069216A (en) * 1975-06-16 1978-01-17 Edward Shanbrom, Inc. Simplified methods for preparation of very high purity Factor VIII concentrate
US4089944A (en) 1975-12-22 1978-05-16 Baxter Travenol Laboratories, Inc. Rapidly solubilized AHF composition and process for preparing same
JPS52125609A (en) * 1976-04-09 1977-10-21 Green Cross Corp:The Purification of agglutination factor viii
DE2624373C2 (de) * 1976-05-31 1983-02-03 Arnold Dr. 8782 Karlstadt Seufert Verfahren zur Herstellung von steril filtriertem Kryopräzipilat mit einer Anreicherung des Faktors VIII
CA1074698A (en) * 1977-12-19 1980-04-01 Gail A. Rock Method of collecting anti-hemophilic factor viii from blood and blood plasma
AT359646B (de) * 1979-04-19 1980-11-25 Immuno Ag Verfahren zur herstellung von nebenwirkungs- freien plasmafraktionen
US4278594A (en) * 1979-06-19 1981-07-14 David Amrani Process for separation and isolation of AHF, von Willebrand's ristocetin cofactor (VWF:RCF) and fibronectin from blood plasma
US4210580A (en) * 1979-06-19 1980-07-01 David Amrani Process for separation and isolation of AHF and fibronectin from blood plasma
US4289691A (en) * 1980-01-18 1981-09-15 The Canadian Red Cross Society Method of obtaining intermediate purity factor VIII
DE3163003D1 (en) * 1980-01-18 1984-05-17 Canadian Red Cross Method of obtaining factor viii
US4305871A (en) * 1980-09-02 1981-12-15 Edward Shanbrom Method of selectively increasing yield and purity of certain cryoprecipitate proteins by heating
CA1178887A (en) * 1981-10-01 1984-12-04 Gail A. Rock Factor viii concentrates prepared from heparinized plasma by the application of a cold precipitation technique
US4397841A (en) 1982-06-28 1983-08-09 Monsanto Company Production of blood coagulation factor VIII:C
US5149787A (en) * 1984-05-22 1992-09-22 The Blood Center Research Foundation Method for maintaining intact, non-degraded factor VIII/von-Willebrand factor during blood processing
US4543210A (en) * 1984-10-04 1985-09-24 Miles Laboratories, Inc. Process for producing a high purity antihemophilic factor concentrate
GB8505882D0 (en) * 1985-03-07 1985-04-11 Central Blood Lab Authority Purification of blood coagulation factor viii
DE3684459D1 (de) * 1986-03-27 1992-04-23 Octapharma Ag Verfahren zur herstellung eines hochgereinigten antihaemophilie-faktors.
USH1509H (en) * 1989-06-09 1995-12-05 Eran; Harutyun Heparin enhanced process for separating antihemophilic factor (Factor VIII) and fibronectin from cryoprecipitate
FR2651437A1 (fr) * 1989-09-05 1991-03-08 Lille Transfusion Sanguine Procede de preparation de concentre du complexe facteur viii-facteur von willebrand de la coagulation sanguine a partir de plasma total.
FR2657884B1 (fr) * 1990-02-05 1994-09-02 Tm Innovation Procede pour la preparation du facteur viii humain et d'analogues du facteur viii.
IT1248723B (it) * 1990-06-12 1995-01-26 Scalvo S P A Processo per la purificazione del fattore viii e fattore viii ottenuto con tale processo
US5278289A (en) * 1991-11-12 1994-01-11 Johnson Alan J Antihemophilic factor stabilization
US5659017A (en) * 1995-11-07 1997-08-19 Alpha Therapeutic Corporation Anion exchange process for the purification of Factor VIII
US8389687B2 (en) * 2000-10-23 2013-03-05 Shanbrom Technologies, Llc Polyvinylpyrrolidone cryoprecipitate extraction of clotting factors
US7297716B2 (en) * 2000-10-23 2007-11-20 Shanbrom Technologies, Llc Enhanced production of blood components, blood cells and plasma without freezing
US6881731B1 (en) * 2000-10-23 2005-04-19 Shanbrom Technologies, Llc Enhancers for microbiological disinfection
US7411006B2 (en) * 2000-10-23 2008-08-12 Shanbrom Technologies, Llc Enhanced production of blood clotting factors and fibrin fabric
EP1363616A1 (de) * 2001-02-07 2003-11-26 Shanbrom Technologies, LLC Carbonsäure wie citronsäure zur desinfektion oder steigerung der produktion von blutprodukten wie plasma, kryopräzipitat und/oder blutplätchen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2867567A (en) * 1955-01-21 1959-01-06 Nat Res Dev Process of preparing anti-haemophilic globulin
DE1949314U (de) 1966-05-07 1966-11-10 Braun Fa B Bohrdraht-bereitschaftskasten.
BE713764A (de) 1967-05-01 1968-09-16 Baxter Travenol Lab
US3652530A (en) * 1967-08-28 1972-03-28 American Nat Red Cross Antihemophilic factor prepared from blood plasma using polyethylene glycol
US3560475A (en) * 1969-06-19 1971-02-02 Baxter Laboratories Inc Prothrombin complex prepared by precipitation with polyethylene glycol
US3631018A (en) * 1970-05-01 1971-12-28 Baxter Laboratories Inc Production of stable high-potency human ahf using polyethylene glycol and glycine to fractionate a cryoprecipitate of ahf concentrate
US3682881A (en) * 1970-10-02 1972-08-08 Baxter Laboratories Inc Fractionation of plasma using glycine and polyethylene glycol

Also Published As

Publication number Publication date
JPS4956695A (de) 1974-06-01
IL42221A0 (en) 1973-07-30
CH630804A5 (de) 1982-07-15
AU5584973A (en) 1974-11-21
SE430020B (sv) 1983-10-17
DE2324717B2 (de) 1980-01-03
IL42221A (en) 1977-04-29
NL7306806A (de) 1973-11-20
USRE29698E (en) 1978-07-11
ES414823A1 (es) 1976-02-01
BE799525A (fr) 1973-08-31
DK136016B (da) 1977-08-01
DK136016C (de) 1978-01-02
ATA433573A (de) 1975-04-15
US3803115A (en) 1974-04-09
ZA733138B (en) 1974-03-27
AU465351B2 (en) 1975-09-25
JPS596845B2 (ja) 1984-02-15
NO142381C (no) 1980-08-13
GB1372515A (en) 1974-10-30
IT1061433B (it) 1983-02-28
DE2324717A1 (de) 1973-12-13
FR2184898A1 (de) 1973-12-28
CA1007986A (en) 1977-04-05
NO142381B (no) 1980-05-05
DE2324717C3 (de) 1983-12-01
FR2184898B1 (de) 1976-11-05

Similar Documents

Publication Publication Date Title
AT344881B (de) Verfahren zur herstellung von antihaemophilfaktor (ahf)-konzentrat
AT356881B (de) Verfahren zur herstellung von spanplatten
AT327946B (de) Verfahren zur herstellung von n-phosphonomethylglycin
AT327157B (de) Verfahren zur herstellung von dimethylather
AT329203B (de) Verfahren zur herstellung von neuen heptapeptiden
ATA583473A (de) Verfahren zur herstellung von neuen sufonamidodiphenylathern
DD108102A5 (de) Verfahren zur herstellung von pfropfcopolymeren
AT327180B (de) Verfahren zur herstellung von anthrachinon
AT342193B (de) Verfahren zur herstellung von sterolinreichen produkten
AT327945B (de) Verfahren zur herstellung von n-phosphonomethylglycin
AT336634B (de) Verfahren zur herstellung von poly-n-alkyliminoalanen
DD108516A5 (de) Verfahren zur herstellung von 2-substituierten-4(r)-hydroxy-2-cyclopenthen-1-on
DD104533A5 (de) Verfahren zur herstellung von olefintetrapolymeren
AT329525B (de) Verfahren zur herstellung von polyalkenen
AT334177B (de) Verfahren zur herstellung von emulsionen
AT327176B (de) Verfahren zur herstellung von tetrabromphthalsaureanhydrid
AT358520B (de) Verfahren zur herstellung von briketts
DD101328A1 (de) Verfahren zur herstellung von Verbundmaterial
AT350045B (de) Verfahren zur herstellung von n-(diaethylamino- aethyl)-2-methoxy-4-amino-5-chlorbenzamid
AT330379B (de) Verfahren zur herstellung von cis-zearalenen
AT322099B (de) Verfahren zur herstellung von rifamycin b
AT321895B (de) Verfahren zur herstellung von dl-threo-1-p-nitrophenyl-2-acetamino-1,3-propandiol
DE2219605A1 (de) Verfahren zur herstellung von antimagnetismus
AT323715B (de) Verfahren zur herstellung von neuen substituierten sulfonylmethylbicycloalkenonen
AT324298B (de) Verfahren zur herstellung von neuen substituierten bicycloalkenonen

Legal Events

Date Code Title Description
EFA Change in the company name
ELA Expired due to lapse of time